Strategic Acquisition Asolva was acquired by Harris Corporation in March 2023, indicating a strategic move to scale antimicrobial stewardship solutions. This presents a potential upsell opportunity to Harris’ client base and a channel to co-sell expanded infection control analytics offerings.

Healthcare Focus Specializes in clinical analytics software for hospitals of all sizes to combat antimicrobial resistance. This positions the company to target healthcare providers prioritizing antimicrobial stewardship, infection control, and data-driven outcomes.

Niche Competency Partnership with the CDC and a validated approach to antimicrobial stewardship signaling credibility with regulated buyers. Prospect opportunities include hospitals seeking compliance-aligned analytics and vendor validation support.

Growth Potential Small company footprint with revenue under one million suggests agility and customization, making it attractive to mid-market hospitals and health systems seeking tailored analytics without enterprise-scale frictions.

Digital Footprint Tech stack and digital marketing footprint (Cloud, analytics, SEO, and web technologies) enable scalable deployment of analytics solutions and potential for expanding digital marketing partnerships to reach new hospital customers.